| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-86-4-394 |
| P698 | PubMed publication ID | 848800 |
| P2093 | author name string | G. P. Rodnan | |
| J. A. Shaver | |||
| D. F. Leon | |||
| R. Salerni | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | arterial hypertension | Q41861 |
| CREST syndrome | Q763356 | ||
| pulmonary hypertension | Q1128595 | ||
| P304 | page(s) | 394-399 | |
| P577 | publication date | 1977-04-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma) | |
| P478 | volume | 86 |
| Q33606645 | Abnormalities in the regulators of angiogenesis in patients with scleroderma |
| Q54282917 | Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease |
| Q36182730 | Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis |
| Q68978807 | Antinuclear antibodies in primary pulmonary hypertension |
| Q40435628 | Autopsy case of systemic sclerosis with severe pulmonary hypertension |
| Q92600821 | Biomaterials to Mimic and Heal Connective Tissues |
| Q35948265 | Bronchioloalveolar carcinoma in progressive systemic sclerosis |
| Q33565869 | CREST syndrome with pericardial but not peripheral calcinosis |
| Q41220227 | Cardiac involvement in scleroderma |
| Q70280157 | Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease |
| Q38218044 | Clinical and laboratory profiles of 136 systemic sclerosis patients with and without echocardiographically detected pulmonary hypertension |
| Q33555517 | Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration |
| Q74600554 | Clinical classification of pulmonary hypertension |
| Q45085598 | Cytotoxic effects of sera from patients with systemic scleroderma: comparison of three different in vitro methods |
| Q56978382 | Dépistage de l’hypertension artérielle pulmonaire au cours de la sclérodermie systémique : étude d’une cohorte de 67 patients |
| Q35127435 | Endothelin and endothelin receptor antagonists in systemic rheumatic disease |
| Q35564258 | Evaluation and management of pulmonary hypertension in systemic sclerosis |
| Q67689426 | Failure of vasodilator infusion to alter pulmonary diffusing capacity in systemic sclerosis |
| Q39341619 | Immune complexes and antinuclear, antinucleolar, and anticentromere antibodies in scleroderma |
| Q70358811 | Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus |
| Q34536425 | Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension |
| Q34990080 | Life-threatening complications of systemic sclerosis |
| Q67599142 | Long-term follow-up study of 164 patients with definite systemic sclerosis: classification considerations |
| Q71653928 | Long‐term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases |
| Q40921135 | Lung disease in systemic sclerosis (scleroderma). |
| Q74629663 | Lung transplantation for pulmonary hypertension: patient selection and maintenance therapy while awaiting transplantation |
| Q77903302 | Manifestations of scleroderma pulmonary disease |
| Q35169049 | Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being |
| Q35000083 | Nuclear autoantigen CENP-B transactivation of the epidermal growth factor receptor via chemokine receptor 3 in vascular smooth muscle cells |
| Q70957371 | Occurrence of scleroderma in a chronic carrier of HBs antigen. Critical analysis of the possible role of HBs-anti-HBs immune complexes |
| Q73487850 | Organizing diffuse alveolar damage associated with progressive systemic sclerosis |
| Q40847312 | Pathology of a new toxic syndrome caused by ingestion of adulterated oil in Spain |
| Q35803193 | Persistent vascular collagen accumulation alters hemodynamic recovery from chronic hypoxia |
| Q35552142 | Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach |
| Q36182733 | Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies |
| Q44933148 | Primary pulmonary hypertension associated with systemic lupus erythematosus |
| Q34758143 | Prostacyclin for pulmonary hypertension |
| Q24246933 | Prostacyclin for pulmonary hypertension in adults |
| Q37084786 | Pulmonary arterial hypertension from a pediatric perspective |
| Q53102154 | Pulmonary arterial hypertension in SLE: what do we know? |
| Q36013674 | Pulmonary arterial hypertension in systemic sclerosis: clinical manifestations, pathophysiology, evaluation, and management |
| Q43891962 | Pulmonary hypertension associated with connective tissue diseases |
| Q34377981 | Pulmonary hypertension associated with primary biliary cirrhosis in the absence of portal hypertension: a case report |
| Q43423345 | Pulmonary hypertension in MCTD: report of two cases with anticardiolipin antibody |
| Q33592469 | Pulmonary hypertension in collagen vascular disease |
| Q33324452 | Pulmonary hypertension in connective tissue disease. Report of three cases and review of the literature |
| Q33556953 | Pulmonary hypertension in hydralazine induced systemic lupus erythematosus: association with C4 null allele |
| Q40896227 | Pulmonary hypertension in systemic autoimmune disease |
| Q54544457 | Pulmonary hypertension in systemic lupus erythematosus: hemodynamics and effects of vasodilator therapy. |
| Q36999306 | Pulmonary renal syndromes--a review. |
| Q40265664 | Pulmonary renal syndromes. II. Etiology and pathogenesis |
| Q39854610 | Pulmonary vascular changes in scleroderma |
| Q33591261 | Radiology of the right ventricle |
| Q36450708 | Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study. |
| Q34094102 | Risk factors for pulmonary arterial hypertension. |
| Q64078418 | Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study |
| Q71581583 | Scleroderma |
| Q71371699 | Scleroderma and other diseases associated with cutaneous sclerosis |
| Q35939760 | Scleroderma and the kidney |
| Q40922425 | Scleroderma. Clinical problems. The lungs |
| Q37098199 | Severe Pulmonary Hypertension in Primary Sjögren's Syndrome |
| Q40375438 | Severe pulmonary hypertension in a patient with rheumatoid arthritis--response to nifedipine. |
| Q36705798 | The CREST syndrome--successful reduction of pulmonary hypertension by captopril |
| Q34707690 | The nuclear autoantigen CENP-B displays cytokine-like activities toward vascular smooth muscle cells |
| Q33611165 | The treatment of primary pulmonary hypertension |
| Q33634193 | Treatment of pulmonary hypertension secondary to connective tissue diseases. |
| Q44867308 | Two fatal cases of mixed connective tissue disease. Description of case histories terminating as progressive systemic sclerosis |
| Q38037773 | Utility of serologic testing in the diagnosis of noninfectious pulmonary disorders |
| Q53841818 | Value and limitations of calcium channel blockade in the treatment of pulmonary hypertension associated with CREST--case reports. |
| Q37344793 | Vascular disease in scleroderma |
| Q70428677 | Vasodilator therapy of pulmonary hypertension in the CRST syndrome |
| Q73200563 | [Primary pulmonary hypertension: a rare but often fatal complication of Crest syndrome] |
| Q68138012 | [Pulmonary arterial hypertension and systemic lupus erythematosus. Apropos of 2 cases. Review of the literature] |
| Q73245714 | [Pulmonary involvement in systemic scleroderma. Part I. Chronic fibrosing interstitial lung disease] |
| Q73245719 | [Pulmonary involvement in systemic scleroderma. Part II. Isolated pulmonary arterial hypertension, bronchopulmonary cancer, alveolar hemorrhage] |
| Q80953210 | [The methods for screening pulmonary hypertension related to systemic sclerosis in France. Descriptive survey of the French Research Group on Sclerosis] |
| Q70278049 | [Value of captopril in the treatment of systemic arterial and pulmonary hypertension with increased plasma renin in scleroderma] |
Search more.